Collegium Pharmaceutical Announces the Spin-out of Onset Therapeutics and the Launch of PreCision Dermatology Inc
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market.

Read more on Business Wire via Yahoo! Finance